Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 4, 2013, Pages 349-357

  Egstrup, M ^a   Kistorp, C N ^b   Schou, M ^c   Hofsten, D E ^c   Moller, J E ^c   Tuxen, C D ^d   Gustafsson, I ^b  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Contractile reserve; Diabetes mellitus; Dobutamine stress echocardiography; Exercise capacity; Glucose metabolism; Heart failure

Indexed keywords

DOBUTAMINE;

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE INTOLERANCE; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HEART EJECTION FRACTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LEFT VENTRICULAR CONTRACTILE RESERVE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84875193540     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes165     Document Type: Article

References (34)

1. Kamalesh M, Subramanian U, Sawada S, Eckert G, Temkit M, Tierney W. Decreased survival in diabetic patients with heart failure due to systolic dysfunction. Eur J Heart Fail 2006;8:404-8.
2. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J 2008;29: 1377-85.
3. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Kober L et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004;43: 771-7.
4. Tibb AS, Ennezat PV, Chen JA, Haider A, Gundewar S, Cotarlan V et al. Diabetes lowers aerobic capacity in heart failure. J Am Coll Cardiol 2005;46:930-1.
5. Ingle L, Reddy P, Clark AL, Cleland JG. Diabetes lowers six-minute walk test performance in heart failure. J Am Coll Cardiol 2006;47:1909-10.
6. Egstrup M, Schou M, Gustafsson I, Kistorp CN, Hildebrandt PR, Tuxen CD. Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis. Eur J Heart Fail 2011;13:319-26.
7. Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Bragadeesh T et al. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart 2009;95:917-23.
8. Suskin N. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000;21:1368-75.
9. Yazici M, Ozdemir K, Gonen MS, Kayrak M, Ulgen MS, Duzenli MA et al. Is there any relationship between metabolic parameters and left ventricular functions in type 2 diabetic patients without evident heart disease? Echocardiography 2008; 25:675-82.
10. Karamitsos TD, Karvounis HI, Dalamanga EG, Papadopoulos CE, Didangellos TP, Karamitsos DT et al. Early diastolic impairment of diabetic heart: the significance of right ventricle. Int J Cardiol 2007;114:218-23.
11. Dinh W, Lankisch M, Nickl W, Scheyer D, Scheffold T, Kramer F et al. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovasc Diabetol 2010;9:63.
12. Ha JW, Ahn JA, Kim JM, Choi EY, Kang SM, Rim SJ et al. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2006;19:1314-9.
13. Govind S, Brodin LA, Nowak J, Quintana M, Raumina S, Ramesh SS et al. Isolated type 2 diabetes mellitus causes myocardial dysfunction that becomes worse in the presence of cardiovascular diseases: results of the myocardial doppler in diabetes (MYDID) study 1. Cardiology 2005;103:189-95.
14. Govind S, Saha S, Brodin LA, Ramesh SS, Arvind SR, Quintana M. Impaired myocardial functional reserve in hypertension and diabetes mellitus without coronary artery disease: searching for the possible link with congestive heart failure in the myocardial Doppler in diabetes (MYDID) study II. Am J Hypertens 2006;19: 851-857. Discussion 858.
15. Govind SC, Brodin LA, Nowak J, Arvind SR, Ramesh SS, Netyo A et al. Microalbuminuria and left ventricular function in type 2 diabetes: a quantitative assessment by stress echocardiography in the Myocardial Doppler in Diabetes (MYDID) Study III. Scand Cardiovasc J 2007;41:363-9.
16. Galderisi M, de Simone G, Innelli P, Turco A, Turco S, Capaldo B et al. Impaired inotropic response in type 2 diabetes mellitus: a strain rate imaging study. Am J Hypertens 2007;20:548-55.
17. Terzi S, Sayar N, Bilsel T, Enc Y, Yildirim A, Ciloglu F et al. Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure. Heart Vessels 2007;22:237-44.
18. Hamdan A, Shapira Y, Bengal T, Mansur M, Vaturi M, Sulkes J et al. Tissue Doppler imaging in patients with advanced heart failure: relation to functional class and prognosis. J Heart Lung Transplant 2006;25:214-8.
19. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27:132-9.
20. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89.
21. Alberti KGMM. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Report of a WHO Consultation. Geneva: World Health Organizatio.n.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function fromfasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-9.
23. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-33.
24. Ramahi TM, Longo MD, Cadariu AR, Rohlfs K, Slade M, Carolan S et al. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. Eur Heart J 2001;22:849-56.
25. Sicari R, Picano E, Cortigiani L, Borges AC, Varga A, Palagi C et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 2003;92:1263-6.
26. Prior JO, Quinones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005;111:2291-8.
27. Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay AT, Altan VM. The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts. Diabetes 2001;50:455-61.
28. Sacre JW, Franjic B, Jellis CL, Jenkins C, Coombes JS, Marwick TH. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging 2010;3:1207-15.
29. Kotsanas G, Delbridge LM, Wendt IR. Stimulus interval-dependent differences in Ca2+ transients and contractile responses of diabetic rat cardiomyocytes. Cardiovasc Res 2000;46:450-62.
30. Takeda N, Nakamura I, Hatanaka T, Ohkubo T, Nagano M. Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats. Jpn Heart J 1988; 29:455-63.
31. Otasevic P, Popovic ZB, Vasiljevic JD, Vidakovic R, Pratali L, Vlahovic A et al. Relation of myocardial histomorphometric features and left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 2005;7:49-56.
32. Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med 2010;27:977-87.
33. Straburzynska-Migaj E, Ochotny R, Cieslinski A. Impaired glucose tolerance worsens exercise capacity and ventilatory response to exercise in patients with chronic heart failure. Kardiol Pol 2007;65:354-60. Discussion 361-52.
34. Piepoli M, Clark AL, Coats AJ. Muscle metaboreceptors in hemodynamic, autonomic, and ventilatory responses to exercise in men. Am J Physiol 1995;269: H1428-36.